Suppr超能文献

相似文献

1
Taccalonolide microtubule stabilizers.
Bioorg Med Chem. 2014 Sep 15;22(18):5091-6. doi: 10.1016/j.bmc.2014.01.012. Epub 2014 Jan 15.
3
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Cancer Res. 2013 Nov 15;73(22):6780-92. doi: 10.1158/0008-5472.CAN-13-1346. Epub 2013 Sep 18.
5
Taccalonolide Microtubule Stabilizers.
Prog Chem Org Nat Prod. 2020;112:183-206. doi: 10.1007/978-3-030-52966-6_3.
6
Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
J Nat Prod. 2019 Mar 22;82(3):583-588. doi: 10.1021/acs.jnatprod.8b01036. Epub 2019 Feb 25.
7
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Cell Cycle. 2011 Jul 1;10(13):2162-71. doi: 10.4161/cc.10.13.16238.
9
Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
J Nat Prod. 2017 Feb 24;80(2):409-414. doi: 10.1021/acs.jnatprod.6b00944. Epub 2017 Jan 23.
10
Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.
J Nat Prod. 2013 Jul 26;76(7):1369-75. doi: 10.1021/np400435t. Epub 2013 Jul 15.

引用本文的文献

3
Taccalonolides: Structure, semi-synthesis, and biological activity.
Front Pharmacol. 2022 Aug 11;13:968061. doi: 10.3389/fphar.2022.968061. eCollection 2022.
4
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
5
Taccalonolides: A Novel Class of Microtubule-Stabilizing Anticancer Agents.
Cancers (Basel). 2021 Feb 22;13(4):920. doi: 10.3390/cancers13040920.
8
Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.
J Comput Aided Mol Des. 2019 Jul;33(7):627-644. doi: 10.1007/s10822-019-00208-w. Epub 2019 May 31.
9
The Search for Anticancer Agents from Tropical Plants.
Prog Chem Org Nat Prod. 2018;107:1-94. doi: 10.1007/978-3-319-93506-5_1.

本文引用的文献

1
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Cancer Res. 2013 Nov 15;73(22):6780-92. doi: 10.1158/0008-5472.CAN-13-1346. Epub 2013 Sep 18.
2
Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.
J Nat Prod. 2013 Jul 26;76(7):1369-75. doi: 10.1021/np400435t. Epub 2013 Jul 15.
3
Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.
Biochem Pharmacol. 2013 Apr 15;85(8):1104-14. doi: 10.1016/j.bcp.2013.01.030. Epub 2013 Feb 8.
4
Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Science. 2013 Feb 1;339(6119):587-90. doi: 10.1126/science.1230582. Epub 2013 Jan 3.
7
Taccalonolides: a microtubule stabilizer poses a new puzzle with old pieces.
Cell Cycle. 2011 Oct 1;10(19):3233-4. doi: 10.4161/cc.10.19.17126.
8
Identification and biological activities of new taccalonolide microtubule stabilizers.
J Med Chem. 2011 Sep 8;54(17):6117-24. doi: 10.1021/jm200757g. Epub 2011 Aug 11.
9
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Cell Cycle. 2011 Jul 1;10(13):2162-71. doi: 10.4161/cc.10.13.16238.
10
Mitosis is not a key target of microtubule agents in patient tumors.
Nat Rev Clin Oncol. 2011 Feb 1;8(4):244-50. doi: 10.1038/nrclinonc.2010.228.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验